Photo from wikipedia
This randomized clinical trial evaluates whether treatment with the dopaminergic agonist rotigotine has an effect on cognitive function in patients with mild to moderate Alzheimer disease in Italy. Click to show full abstract
This randomized clinical trial evaluates whether treatment with the dopaminergic agonist rotigotine has an effect on cognitive function in patients with mild to moderate Alzheimer disease in Italy.
Keywords:
alzheimer disease;
rotigotine;
moderate alzheimer;
effect;
patients mild;
mild moderate
Journal Title: JAMA Network Open
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!